Selective Dentine Removal in Primary Teeth
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03872037 |
|
Recruitment Status :
Completed
First Posted : March 12, 2019
Last Update Posted : March 14, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background There is little information regarding the longevity of the restored tooth, considering the health of the pulp-dentine complex, in children who do not sufficiently cooperate with dental treatment.
Aim To evaluate the longevity of primary molar teeth with an occluso-proximal cavity that was treated with the selective removal of carious tissue.
Design A total of 150 children were allocated to two parallel groups: group 1 (G1, n = 70, control, Ketac Molar Easymix®, 3M/ESPE, Seefeld, GE) and group 2 (G2, n = 80, test, Maxxion®, FGM, Joinville, BR). The study was double-blinded, and an operator specialized in paediatric dentistry performed the selective removal of soft dentine and the restoration of the cavity with GIC. During the follow-up periods, the teeth were evaluated via periapical radiography by two trained examiners specialized in radiology. Statistical analysis was performed using Stata 11.2 software (StataCorp, Texas, USA) and a survival curve (Kaplan-Meier).
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Caries, Dental | Procedure: Selective removal of carious tissue and restoration with Maxxion Procedure: Control | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 150 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | A total of 150 children were allocated to two parallel groups: group 1 (G1, n = 70, control, Ketac Molar Easymix®, 3M/ESPE, Seefeld, GE) and group 2 (G2, n = 80, test, Maxxion®, FGM, Joinville, BR). The study was double-blinded, and an operator specialized in paediatric dentistry performed the selective removal of soft dentine and the restoration of the cavity with GIC. During the follow-up periods, the teeth were evaluated via periapical radiography by two trained examiners specialized in radiology. Statistical analysis was performed using Stata 11.2 software (StataCorp, Texas, USA) and a survival curve (Kaplan-Meier). |
| Masking: | Double (Participant, Investigator) |
| Masking Description: | For the radiographic evaluation, the evaluators had no information about the group to which the parent was randomized. Only the periapical tissues were evaluated, and the coronary portion of the restored tooth was concealed with adhesive tape. |
| Primary Purpose: | Treatment |
| Official Title: | Selective Dentine Removal in Primary Teeth: a Randomized Clinical Trial |
| Actual Study Start Date : | July 2, 2014 |
| Actual Primary Completion Date : | February 3, 2016 |
| Actual Study Completion Date : | February 3, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Control
Molars subjected to selective removal and restored with Ketac Molar Easymix
|
Procedure: Control
Molars subjected to selective removal and restored with Ketac Molar Easymix |
|
Experimental: Selective removal of caries and restoration with Maxxion
Molars subjected to selective removal and restored with Maxxion
|
Procedure: Selective removal of carious tissue and restoration with Maxxion
Molars subjected to selective removal and restored with Maxxion |
- Number of teeth with treatment-related success as assessed by radiographic analysis. [ Time Frame: 14-month ]To evaluate the longevity of primary molar teeth with an occluso-proximal cavity that was treated with the selective removal of carious tissue.
- Number of teeth with treatment-related success as assessed by radiographic analysis. [ Time Frame: 24-month ]To evaluate the longevity of primary molar teeth with an occluso-proximal cavity that was treated with the selective removal of carious tissue.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 4 Years to 5 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- An active denture caries lesion
- The molars in primary, without anterior restoration, with the exclusive involvement of occlusal and mesial or distal surfaces present (International Caries Detection and Evaluation System, ICDAS score 5)
Exclusion Criteria:
- Those who did not accept care after 3 adaptation sessions
- Teeth with the following characteristics were excluded from the study: spontaneous pain, pressure sensitivity, suspected cellulose involvement, necrosis pulp, fistula, or tooth mobility
- Teeth in which extension of the lesion could lead to pulpal exposure were excluded
- Children whose parents or guardians do not sign an Informed Consent Term
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03872037
| Brazil | |
| Faculty Sao Leopoldo Mandic | |
| Campinas, Sao Paulo, Brazil, 13045755 | |
| Principal Investigator: | Jose Carlos P Imparato, PhD | Sao Leopoldo Mandic |
| Responsible Party: | Jose Carlos P Imparato, PhD, Senior Lecturer, Clinical Professor, Faculty Sao Leopoldo Mandic Campinas |
| ClinicalTrials.gov Identifier: | NCT03872037 |
| Other Study ID Numbers: |
SLM 7 |
| First Posted: | March 12, 2019 Key Record Dates |
| Last Update Posted: | March 14, 2019 |
| Last Verified: | March 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
minimally invasive dentistry dental caries dentine |
|
Dental Caries Tooth Demineralization Tooth Diseases Stomatognathic Diseases |

